|
|
Article: A Phase III Alzheimer's Drug Increases Levels of Beta Amyloid in the Brain - But Still Provides Benefits
- Article from:
- U.S. Newswire
- Article date:
- July 15, 2009
CopyrightCopyright 2009 U.S. Newswire. Provided by ProQuest LLC. (Hide copyright information)
|
To: NATIONAL EDITORS
Contact: CONTACT: Alzheimer's Association media line, +1-312-335-
4078, media@alz.org; or ICAD 2009 press room, July 11-16: +43 (0)1
931020 7501
VIENNA, July 15 /PRNewswire-USNewswire/ -- New insights into how
a Phase III Alzheimer's drug might work were among the advances in
potential therapies targeting two abnormal brain proteins - beta
amyloid and phosphorylated tau - that were reported today at the
Alzheimer's Association 2009 International Conference on Alzheimer's
Disease (ICAD 2009) in Vienna.
(Logo: http://www.newscom.com/cgi-bin/prnh/20090529/ICADLOGO)
Scientists also reported on how clinicians view and treat mild
cognitive impairment (MCI), a research ...